The Surge of E-pharma

The increase in coronavirus cases has continually exposed businesses and people to new risks and unforeseen possibilities this year. The pharmaceutical industry is facing the most turbulent times due to increased recognition and demand for pharmaceuticals like never before. The challenges they face are the harsh realities of this pandemic, such as shortages of APIs (active active ingredients), increased demand for R&D decisions and the search for a change in market dynamics.
The EP pharmaceutical market also saw a sudden surge due to this market dynamics during the second foreclosure. One of the factors driving the…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Jefferies Jiang

Jefferies Jiang

I make articles on AI and leadership.